Evidence
Front Immunol. 2023 Mar 30;14:1137034. doi: 10.3389/fimmu.2023.1137034. eCollection 2023.
ABSTRACT
The natural killer (NK) cell population is a critical component of the innate immune compartment of the liver, and its functions are deeply affected by the surrounding environment. In the late stage of fibrosis, NK cells become dysfunctional, but the influence of disease etiology on NK cell behavior during cirrhosis remains unclear. Using single-cell RNA sequencing (scRNA-seq), we characterized the hepatic NK cells from end-stage cirrhotic livers from subjects with non-alcoholic steatohepatitis (NASH), chronic hepatitis C infection (HCV) and primary sclerosing cholangitis (PSC). Here, we show that although NK cells shared similar dysfunctions, the disease etiology impacts hepatic NK cell heterogeneity. Therapeutical strategies targeting NK cells for the prevention or treatment of fibrosis should consider liver disease etiology in their design.
PMID:37063898 | PMC:PMC10098346 | DOI:10.3389/fimmu.2023.1137034
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Etiology of end-stage liver cirrhosis impacts hepatic natural killer cell heterogenicity
🌐 90 Days
VR Related Evidence Matrix
- Diverse potential of secretome from natural killer cells and monocyte-derived macrophages in activating stellate cells
- Liver cirrhosis in a patient with alcohol dependence and autoimmune hepatitis
- Dynamics of cellular plasticity in non-alcoholic steatohepatitis (NASH)
- Osr1-mediated mesothelial transition of liver mesenchymal cells exacerbates fibrotic liver damage
- The double roles of T cell-mediated immune response in the progression of MASLD
- The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance
- Comparative Analysis of Single-Cell RNA Sequencing Methods with and without Sample Multiplexing
- Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation
- Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation
- Galectin-3 and Severity of Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease
- HIV/HBV co-infection remodels the immune landscape and Natural Killer cell ADCC functional responses
- Interleukins in liver disease treatment
- Crosstalk in extrahepatic and hepatic system in NAFLD/NASH
- Crosstalk in extrahepatic and hepatic system in NAFLD/NASH
- Advancements in Single-Cell RNA Sequencing Research for Neurological Diseases
- In Vitro to In Vivo Scalars for Drug Clearance in Non-Alcoholic Fatty Liver and Steatohepatitis
- Three-Dimensional Structure of Novel Liver Cancer Biomarker Liver Cancer-Specific Serine Protease Inhibitor Kazal (LC-SPIK) and Its Performance in Clinical Diagnosis of Hepatocellular Carcinoma (HCC)
- Unveiling spatial complexity in solid tumor immune microenvironments through multiplexed imaging
- Spatial genomics: mapping human steatotic liver disease
- Single-cell RNA-seq data analysis reveals functionally relevant biomarkers of early brain development and their regulatory footprints in human embryonic stem cells (hESCs)
- Single-cell transcriptomic analysis of decidual immune cell landscape in the occurrence of adverse pregnancy outcomes induced by Toxoplasma gondii infection
- Single-cell transcriptomic analysis of decidual immune cell landscape in the occurrence of adverse pregnancy outcomes induced by Toxoplasma gondii infection
- Patients undergoing liver resection for non-alcoholic fatty liver disease-related hepatocellular carcinoma and those for viral hepatitis-related hepatocellular carcinoma have similar survival outcomes
- Periportal macrophages protect against commensal-driven liver inflammation
- Fructose regulates the pentose phosphate pathway and induces an inflammatory and resolution phenotype in Kupffer cells
- Fructose regulates the pentose phosphate pathway and induces an inflammatory and resolution phenotype in Kupffer cells
- COVID-19 in Individuals with Chronic Liver Diseases
- Kupffer cell diversity maintains liver function in alcohol-associated liver disease
- Hedan tablet ameliorated non-alcoholic steatohepatitis by moderating NF-kappaB and lipid metabolism-related pathways via regulating hepatic metabolites
- Bioengineering scalable and drug-responsive in vitro human multicellular non-alcoholic fatty liver disease microtissues encapsulated in the liver extracellular matrix-derived hydrogel
- From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences
- Integrative analysis identifies oxidative stress biomarkers in non-alcoholic fatty liver disease via machine learning and weighted gene co-expression network analysis
- Analysis and Visualization of Single-Cell Sequencing Data with Scanpy and MetaCell: A Tutorial
- The protective effects of Ninjin'yoeito against liver steatosis/fibrosis in a non-alcoholic steatohepatitis model mouse
- NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic-Metabolic Interplay
- Indoleamine 2,3-dioxygenase 1-mediated iron metabolism in macrophages contributes to lipid deposition in nonalcoholic steatohepatitis
- The gut-liver axis in fatty liver disease: role played by natural products
- Unraveling the connection between Hashimoto's Thyroiditis and non-alcoholic fatty liver disease: exploring the role of CD4(+)central memory T cells through integrated genetic approaches
- The role of extracellular vesicles in non-alcoholic steatohepatitis: Emerging mechanisms, potential therapeutics and biomarkers
- Potential diagnostic markers shared between non-alcoholic fatty liver disease and atherosclerosis determined by machine learning and bioinformatic analysis
- Neuronal cell cycle reentry events in the aging brain are more prevalent in neurodegeneration and lead to cellular senescence
- Subpopulation commensalism promotes Rac1-dependent invasion of single cells via laminin-332
- Artificial intelligence for diagnosis and prognosis prediction of natural killer/T cell lymphoma using magnetic resonance imaging
- Regulatory pathways and therapeutic potential of PDE4 in liver pathophysiology
- Epidemiology, therapy and outcome of hepatocellular carcinoma between 2010 and 2019 in Piedmont, Italy
- Epidemiology, therapy and outcome of hepatocellular carcinoma between 2010 and 2019 in Piedmont, Italy
- Anchored-fusion enables targeted fusion search in bulk and single-cell RNA sequencing data
- Iron metabolism and ferroptosis in Non-alcoholic fatty liver disease: what is our next step?
- Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt
- Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt
- Outcomes of Combined Liver-Kidney Transplantation - Single Center Experience
- Bacteroides and NAFLD: pathophysiology and therapy
- Hammerhead-type FXR agonists induce an enhancer RNA Fincor that ameliorates nonalcoholic steatohepatitis in mice
- Imbalance of mitochondrial fusion in peripheral blood mononuclear cells is associated with liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis
- Development of non-alcoholic steatohepatitis is associated with gut microbiota but not with oxysterol enzymes CH25H, EBI2, or CYP7B1 in mice
- Liver histology is associated with long-term clinical outcomes in patients with metabolic dysfunction-associated steatohepatitis
- Emerging roles of RNA-binding proteins in fatty liver disease
- Transcriptomics of Human Brain Tissue in Parkinson's Disease: a Comparison of Bulk and Single-cell RNA Sequencing
- Recruitment or activation of mast cells in the liver aggravates the accumulation of fibrosis in carbon tetrachloride-induced liver injury
- Clinical outcomes of hepatocellular carcinoma surveillance in Melbourne, Australia
- A model of alcoholic liver disease based on different hepatotoxics leading to liver cancer
- Morroniside delays the progression of non-alcoholic steatohepatitis by promoting AMPK-mediated lipophagy
- Changes in the etiology of liver cirrhosis and the corresponding management strategies
- Protective effects of dopamine against non-alcoholic steatohepatitis via inhibiting p65 pathways in vivo and in vitro
Evidence Blueprint
Etiology of end-stage liver cirrhosis impacts hepatic natural killer cell heterogenicity
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Etiology of end-stage liver cirrhosis impacts hepatic natural killer cell heterogenicity
🌐 365 Days
VR Related Evidence Matrix
- Gut-microbiota prompt activation of natural killer cell on alcoholic liver disease
- Invariant natural killer T cells drive hepatic homeostasis in Non-alcoholic fatty liver disease via sustained IL-10 expression in CD170+ Kupffer cells
- Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis
- Diverse potential of secretome from natural killer cells and monocyte-derived macrophages in activating stellate cells
- Hepatic Fibrosis and Cancer: The Silent Threats of Metabolic Syndrome
- Liver cirrhosis in a patient with alcohol dependence and autoimmune hepatitis
- Activation of Kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventions
- Macrophages and the development and progression of non-alcoholic fatty liver disease
- Human γδ T cell Identification from Single-cell RNA Sequencing Datasets by Modular TCR Expression
- Bone marrow monocytes sustain NK cell-poiesis during non-alcoholic steatohepatitis
- Ambiguous Pathogenic Roles of Macrophages in Alcohol-Associated Liver Diseases
- Dysregulated peripheral proteome reveals NASH-specific signatures identifying patient subgroups with distinct liver biology
- A high-trans fat, high-carbohydrate, high-cholesterol, high-cholate diet-induced nonalcoholic steatohepatitis mouse model and its hepatic immune response
- NLRP3: a new therapeutic target in alcoholic liver disease
- Humanized mouse liver reveals endothelial control of essential hepatic metabolic functions
- An optimized protocol for isolation of hepatic leukocytes retrieved from murine and NASH liver biopsies
- Dynamics of cellular plasticity in non-alcoholic steatohepatitis (NASH)
- Thrombospondin 2 is a key determinant of fibrogenesis in non-alcoholic fatty liver disease
- Leveraging spatial transcriptomics data to recover cell locations in single-cell RNA-seq with CeLEry
- Targeting Extracellular RNA Mitigates Hepatic Lipotoxicity and Liver Injury in NASH
- Leveraging single-cell ATAC-seq and RNA-seq to identify disease-critical fetal and adult brain cell types
- Osr1-mediated mesothelial transition of liver mesenchymal cells exacerbates fibrotic liver damage
- Gut microbe and hepatic macrophage polarization in non-alcoholic fatty liver disease
- Isolation and profiling of viable tumor cells from human ex vivo glioblastoma cultures through single-cell transcriptomics
- Antifibrotic activity of carbon quantum dots in a human in vitro model of non-alcoholic steatohepatitis using hepatic stellate cells
- The double roles of T cell-mediated immune response in the progression of MASLD
- The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance
- Altered Frequency, Activation, and Clinical Relevance of Circulating Innate and Innate-Like Lymphocytes in Patients With Alcoholic Liver Cirrhosis
- "Role of Matrix Gla Protein in Transforming Growth Factor-β Signaling and Non-Alcoholic Steatohepatitis in Mice"
- Comparative Analysis of Single-Cell RNA Sequencing Methods with and without Sample Multiplexing
- Multiple Dimensions of using Mesenchymal Stem Cells for Treating Liver Diseases: From Bench to Beside
- Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation
- Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation
- Overexpression of Interleukin-8 Promotes the Progression of Fatty Liver to Nonalcoholic Steatohepatitis in Mice
- AN1284 attenuates steatosis, lipogenesis, and fibrosis in mice with pre-existing non-alcoholic steatohepatitis and directly affects aryl hydrocarbon receptor in a hepatic cell line
- Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): Recent advances
- Advance and Application of Single-cell Transcriptomics in Auditory Research
- The effect of liver disease on hepatic microenvironment and implications for immune therapy
- Identifying a distinct fibrosis subset of NAFLD via molecular profiling and the involvement of profibrotic macrophages
- Anti-Angiogenic Effects of Natural Compounds in Diet-Associated Hepatic Inflammation
- MiR-552-3p Regulates Multiple Fibrotic and Inflammatory genes Concurrently in Hepatic Stellate Cells Improving NASH-associated Phenotypes
- Macrophage heterogeneity role in NAFLD and NASH disease progression
- Single-cell RNA-seq reveals alterations in peripheral CX3CR1 and nonclassical monocytes in familial tauopathy
- Targeting hepatic ceruloplasmin mitigates nonalcoholic steatohepatitis by modulating bile acid metabolism
- Hemocyte Nuclei Isolation from Adult Drosophila melanogaster for snRNA-seq
- A Markov model of fibrosis development in Non-Alcoholic Fatty Liver Disease predicts fibrosis progression in clinical cohorts
- Correlative light and electron microscopy to explore the lytic immunological synapse between natural killer cells and cancer cells
- Novel oral SPT inhibitor CH5169356 inhibits hepatic stellate cell activation and ameliorates hepatic fibrosis in mouse models of non-alcoholic steatohepatitis (NASH)
- Galectin-3 and Severity of Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease
- Single-cell deconvolution reveals high lineage- and location-dependent heterogeneity in mesenchymal multivisceral stage IV colorectal cancer
- Insights of mitochondrial involvement in alcoholic fatty liver disease
- Liver Injury and Regeneration: Current Understanding, New Approaches, and Future Perspectives
- HIV/HBV co-infection remodels the immune landscape and Natural Killer cell ADCC functional responses
- Exploring the Immune Landscape of Cirrhosis through Weighted Gene Co-expression Network Analysis
- Living Donor Liver transplantation in an alloimmunised patient: Immunological challenges and Management in Indian Settings
- Interleukins in liver disease treatment
- Crosstalk in extrahepatic and hepatic system in NAFLD/NASH
- Crosstalk in extrahepatic and hepatic system in NAFLD/NASH
- Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8+ T cells
- CETP-derived Peptide Seq-1, the Key Component of HB-ATV-8 Vaccine Prevents Stress Responses, and Promotes Downregulation of Pro-Fibrotic Genes in Hepatocytes and Stellate Cells
- Case Report: Molecular and microenvironment change upon midostaurin treatment in mast cell leukemia at single-cell level
- Colorectal Cancer in Individuals with Cirrhosis: A Population-Based Study Assessing Practice Patterns, Outcomes, and Predictors of Survival
- Glisson's capsule matrix structure and function is altered in patients with cirrhosis irrespective of aetiology
- Modelling porcine NAFLD by deletion of leptin and defining the role of AMPK in hepatic fibrosis